To determine whether the combination of irradiation and PARP inhibition is effective in suppressing BRCA1-deficient breast cancer, we first tested the efficacy of irradiation together with AZD2281 in MCF7 cells transfected with siRNA against BRCA1. Here, BRCA1 is linked to breast cancer.